A retrospective study on survival analysis and its prognostic factors of prostate cancer patients in Hospital Universiti Sains Malaysia

Background: Prostate cancer is a leading cause of male morbidity and mortality globally and in Malaysia. This study assessed the five-year survival and prognostic factors among prostate cancer patients in Hospital USM, Kelantan. Methodology: We reviewed 150 medical records of patients diagnosed w...

Full description

Bibliographic Details
Main Author: Lutfi, Ahmad Firdaus Ahmad
Format: Thesis
Language:English
Published: 2020
Subjects:
Online Access:http://eprints.usm.my/57236/1/DR%20AHMAD%20FIRDAUS%20BIN%20AHMAD%20LUTFI-24%20pages.pdf
_version_ 1825907652396318720
author Lutfi, Ahmad Firdaus Ahmad
author_facet Lutfi, Ahmad Firdaus Ahmad
author_sort Lutfi, Ahmad Firdaus Ahmad
collection USM
description Background: Prostate cancer is a leading cause of male morbidity and mortality globally and in Malaysia. This study assessed the five-year survival and prognostic factors among prostate cancer patients in Hospital USM, Kelantan. Methodology: We reviewed 150 medical records of patients diagnosed with prostate cancer, from 2009 to 2014. Survival time was analyzed in relation of patient demographics, Gleason score, ASA classification, ECOG scores, PSA level, family history, cancer staging, cancerrelated hematological parameters, and treatment method. Kaplan-Meier survival curves and Cox proportional hazards models are used for the analysis. Results: The prostate cancer five-year survival rate was 84.5%. Overall Kaplan-Meier survival curve showed good median survival times. Univariate regression analysis revealed significant prognostic factors including age (HR=1.06, 95% CI:1.00, 1.11, p=0.034), ASA 3 classification (HR=3.72, 95% CI:1.38, 10.00, p=0.009), ECOG score 2 (HR=17.98, 95% CI:3.98, 81.1, p<0.001), ECOG 3 (HR=33.94, 95% CI:7.41, 150.0, p<0.001), anemia (HR=9.07, 95% CI:3.33, 24.6, p<0.001), High LDH (HR=5.37, 95% CI:1.80, 15.90, p=0.003), High ALP (HR=8.94, 95% CI:3.31, 24.1, p<0.001), Nodular staging (HR=5.87, 95% CI:1.74, 19.85, p=0.004), Metastasis (HR=3.48, 95% CI:1.28, 9.44, p=0.014), Androgen Deprivation Therapy (HR= 0.29, 95% CI:0.08, 0.99, p=0.05) and Chemotherapy (HR=4.57, 95% CI:1.79, 11.6, p=0.001). Conclusion: The five-year survival rate of HUSM patients treated for prostate cancer was 84.5%. The survival rate reduces significantly due to prognostic factors like age, ASA classification, ECOG score, some hematological parameters, cancer staging and chemotherapy. However, patients received the ADT have a better survival rate, which suggests the main role of prompt initiation of the therapy in improving patient survival.
first_indexed 2024-03-06T16:07:22Z
format Thesis
id usm.eprints-57236
institution Universiti Sains Malaysia
language English
last_indexed 2024-03-06T16:07:22Z
publishDate 2020
record_format dspace
spelling usm.eprints-572362023-03-09T06:46:40Z http://eprints.usm.my/57236/ A retrospective study on survival analysis and its prognostic factors of prostate cancer patients in Hospital Universiti Sains Malaysia Lutfi, Ahmad Firdaus Ahmad RC254-282 Neoplasms. Tumors. Oncology (including Cancer) Background: Prostate cancer is a leading cause of male morbidity and mortality globally and in Malaysia. This study assessed the five-year survival and prognostic factors among prostate cancer patients in Hospital USM, Kelantan. Methodology: We reviewed 150 medical records of patients diagnosed with prostate cancer, from 2009 to 2014. Survival time was analyzed in relation of patient demographics, Gleason score, ASA classification, ECOG scores, PSA level, family history, cancer staging, cancerrelated hematological parameters, and treatment method. Kaplan-Meier survival curves and Cox proportional hazards models are used for the analysis. Results: The prostate cancer five-year survival rate was 84.5%. Overall Kaplan-Meier survival curve showed good median survival times. Univariate regression analysis revealed significant prognostic factors including age (HR=1.06, 95% CI:1.00, 1.11, p=0.034), ASA 3 classification (HR=3.72, 95% CI:1.38, 10.00, p=0.009), ECOG score 2 (HR=17.98, 95% CI:3.98, 81.1, p<0.001), ECOG 3 (HR=33.94, 95% CI:7.41, 150.0, p<0.001), anemia (HR=9.07, 95% CI:3.33, 24.6, p<0.001), High LDH (HR=5.37, 95% CI:1.80, 15.90, p=0.003), High ALP (HR=8.94, 95% CI:3.31, 24.1, p<0.001), Nodular staging (HR=5.87, 95% CI:1.74, 19.85, p=0.004), Metastasis (HR=3.48, 95% CI:1.28, 9.44, p=0.014), Androgen Deprivation Therapy (HR= 0.29, 95% CI:0.08, 0.99, p=0.05) and Chemotherapy (HR=4.57, 95% CI:1.79, 11.6, p=0.001). Conclusion: The five-year survival rate of HUSM patients treated for prostate cancer was 84.5%. The survival rate reduces significantly due to prognostic factors like age, ASA classification, ECOG score, some hematological parameters, cancer staging and chemotherapy. However, patients received the ADT have a better survival rate, which suggests the main role of prompt initiation of the therapy in improving patient survival. 2020 Thesis NonPeerReviewed application/pdf en http://eprints.usm.my/57236/1/DR%20AHMAD%20FIRDAUS%20BIN%20AHMAD%20LUTFI-24%20pages.pdf Lutfi, Ahmad Firdaus Ahmad (2020) A retrospective study on survival analysis and its prognostic factors of prostate cancer patients in Hospital Universiti Sains Malaysia. Masters thesis, Universiti Sains Malaysia.
spellingShingle RC254-282 Neoplasms. Tumors. Oncology (including Cancer)
Lutfi, Ahmad Firdaus Ahmad
A retrospective study on survival analysis and its prognostic factors of prostate cancer patients in Hospital Universiti Sains Malaysia
title A retrospective study on survival analysis and its prognostic factors of prostate cancer patients in Hospital Universiti Sains Malaysia
title_full A retrospective study on survival analysis and its prognostic factors of prostate cancer patients in Hospital Universiti Sains Malaysia
title_fullStr A retrospective study on survival analysis and its prognostic factors of prostate cancer patients in Hospital Universiti Sains Malaysia
title_full_unstemmed A retrospective study on survival analysis and its prognostic factors of prostate cancer patients in Hospital Universiti Sains Malaysia
title_short A retrospective study on survival analysis and its prognostic factors of prostate cancer patients in Hospital Universiti Sains Malaysia
title_sort retrospective study on survival analysis and its prognostic factors of prostate cancer patients in hospital universiti sains malaysia
topic RC254-282 Neoplasms. Tumors. Oncology (including Cancer)
url http://eprints.usm.my/57236/1/DR%20AHMAD%20FIRDAUS%20BIN%20AHMAD%20LUTFI-24%20pages.pdf
work_keys_str_mv AT lutfiahmadfirdausahmad aretrospectivestudyonsurvivalanalysisanditsprognosticfactorsofprostatecancerpatientsinhospitaluniversitisainsmalaysia
AT lutfiahmadfirdausahmad retrospectivestudyonsurvivalanalysisanditsprognosticfactorsofprostatecancerpatientsinhospitaluniversitisainsmalaysia